Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing ...

Eli Lilly and Co. plans to bolster its domestic medicine production with a $27B investment in four new U.S. pharmaceutical ...

The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions ...

The FTSE 100 (^FTSE) and European stocks were lower on Thursday as Rolls-Royce (RR.L) announced its first dividend in five ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as ...

One is that Ireland has an unsustainable reliance on intellectual capital we do not own or create. Much of our economy is ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Novo Nordisk stock ...